Immediate versus gradual TocilizuMab discontinuAtion in GIant Cell Arteritis: protocol of the multicentre randomised open-label MAGICA trial

Introduction Giant cell arteritis (GCA) is a large-vessel vasculitis occurring in people aged over 50 years. Recent studies have shown that tocilizumab (TCZ), an anti-IL-6 receptor monoclonal antibody, is remarkably effective in treating GCA and allows significant dose sparing of glucocorticoids. Ho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hervé Devilliers, Maxime Samson, Bernard Bonnotte, Isabelle Fournel, Abderrahmane Bourredjem, Claudie Cladière, Maud Carpentier, Camille Fleck, Amelie Cransac, Marion Cortier, Emilie Galizzi, Marion Brayer, Jean-Louis Alberini
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-10-01
coleção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/15/10/e108115.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!